This is an additional placeholder post. Click the Edit link to modify or delete it, or start a new post. If you like, use this post to tell readers why you started this blog and what you plan to do with it.
Tags » Collaborative Action
PCPC3 urges the entire cancer community to support and get behind the Durbin amendment to the proposed National Defense Authorization Act (NDAA), which will be debated by the U.S. 285 more words
PCPC3 strongly favors continued and increased future funding for the DoD’s Prostate Cancer Research Program
PCPC3 pleased by recommendation NOT to penalize physicians for use of PSA test to screen for prostate cancer risk
PCPC3 and its members are extremely pleased to learn that a key advisory group to Medicare has recommended that the Centers for Medicare & Medicaid Services (CMS) step back from a proposal, initially put forward late in 2015, to penalize physicians financially for performing tests for risk of prostate cancer using the prostate-specific antigen (PSA) test. 242 more words
PCPC3 is pleased to announce that its entire membership has reviewed and is highly supportive of the most recent version of the National Comprehensive Cancer Network’s (NCCN’s) new guidelines for patients on the diagnosis and treatment of prostate cancer. 225 more words
September is Prostate Cancer Awareness Month and many of the leading patient advocacy organizations coordinate key activities for patients and prostate cancer advocates during this month. 427 more words